Privium Fund Management (UK) Ltd - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Privium Fund Management (UK) Ltd ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$291,000
-6.7%
29,000
+15.0%
0.33%
+88.6%
Q1 2022$312,000
-32.2%
25,209
+26.0%
0.18%
-51.8%
Q4 2021$460,000
+3.8%
20,0000.0%0.36%
-23.6%
Q3 2021$443,00020,0000.48%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HealthInvest Partners AB 230,000$993,6001.92%
AlphaCentric Advisors LLC 352,500$1,522,8001.50%
NEA Management Company, LLC 3,969,834$17,149,6830.96%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 573,530$2,477,6500.76%
ARMISTICE CAPITAL, LLC 5,000,000$21,600,0000.38%
IRONWOOD INVESTMENT MANAGEMENT LLC 93,658$404,6030.27%
Artal Group S.A. 1,000,000$4,3200.24%
Virtus ETF Advisers LLC 64,786$279,8760.15%
TANG CAPITAL MANAGEMENT LLC 200,000$864,0000.13%
HighMark Wealth Management LLC 37,499$161,9960.12%
View complete list of AURINIA PHARMACEUTICALS INC shareholders